Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Bayer AG    BAYN   DE000BAY0017


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 

Bayer Stops Sale of Glucose Meter Business

01/09/2013 | 06:07am US/Eastern

By Hendrik Varnholt

FRANKFURT--German pharmaceutical company Bayer AG (>> Bayer AG) will retain its blood glucose meter business, a spokeswoman said Wednesday, confirming a Bloomberg report.

Bayer had put up the unit for sale and had been in talks with French peer Sanofi SA (>> SANOFI) about a deal which could have been valued at around $1.5 billion, people familiar with the matter told Dow Jones Newswires in December.

"We have evaluated several options and decided to retain it," Bayer HealthCare chief Joerg Reinhardt said about the glucose meter business, according to Bloomberg.

Natali Schwab, Eyk Henning and Dana Cimilluca contributed to this story.

Write to Hendrik Varnholt at

Subscribe to WSJ:

Stocks mentioned in the article : Bayer AG, SANOFI
Recommend :
React to this article
Latest news on BAYER AG
1d ago BAYER : Sources Sought Notice - 99-- 655-15-1-113-0008 MEDRAD X-Ray Dye Injector..
1d ago Pricing is key for new heart drugs challenging cheap generics
4d agoDJHealth Care Down as Traders Bet on Growth Areas -- Health-Care Roundup
4d agoDJJ&J, Bayer Aim to Expand Xarelto's Uses
5d ago BAYER : New successes for Bayer's CO2 research
5d ago BAYER CROPSCIENCE : USA Foundation Awards Grant to the Food Bank of Central and ..
6d ago BAYER CROPSCIENCE : USA Foundation Awards $300,000 Grant to the Food Bank of Cen..
6d ago BAYER CROPSCIENCE : USA Foundation Makes Grant to Food Bank of Central & Eastern..
7d ago BAYER : Company driving use of carbon dioxide: -- New successes for Bayer’..
7d ago BAYER CROPSCIENCE : USA Foundation Awards Grant to the Food Bank of Central and ..
Duration : Period :
Bayer AG Technical Analysis Chart | BAYN | DE000BAY0017 | 4-Traders
Income Statement Evolution
Bayer AG : Income Statement Evolution
More Financials
Dynamic quotes